HomeConformal Medical Inc.

Conformal Medical Inc.

CLAAS Stroke Prevention Technology: Promising Clinical Results Presented at 2020 TCT Conference

Both studies investigated Conformal's CLAAS® Technology, a next-generation solution for sealing the left atrial appendage (LAA) in patients with atrial fibrillation.

First Left Atrial Appendage Closures Performed Under Conscious Sedation with its CLAAS Technology at AF Symposium 2020

Drs. Petr Neuzil and Vivek Reddy will present “ICE-Guided Implantation of the Conformal Left Atrial Appendage Closure Device: First Clinical Report” at the AF Symposium meeting in Washington, D.C., January 23-24.

Conformal Medical Announces Presentation of US Feasibility Study Data at TCT 2019 in San Francisco

The study’s principal investigator, William Gray, MD, will present “Second-generation LAA occlusion: Single-size and conforming to a broad range of anatomies.” The Conformal LAAC’s unique foam-based architecture is designed for simpler, more flexible delivery to eliminate the need for general anesthesia.